Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AVE8112 in Patients With Parkinson's Disease

NCT01803945 is registered in ClinicalTrials.gov with Michael J. Fox Foundation for Parkinson's Research as lead sponsor.

NCT NCT01803945
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01803945 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AVE8112 in Patients With Parkinson's Disease
Lead sponsor
Michael J. Fox Foundation for Parkinson's Research
Phase
Phase 1
Overall status
Terminated
Start date
January 31, 2013
Completion date
June 30, 2015
Enrollment
32 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson's disease